2m 2m 2m 2m 2m 2m 2m
Sang Therap (SGMO)
OTC
$0.15-$0.06 (-30.37%)
Price as of May 04, 2026 7:59 PM EDT- $47.6MMarket Cap
- -57.22%1-Year Change
- BiotechnologyIndustry
Sang Therap (SGMO)
$0.15-$0.06 (-30.37%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 47
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.19
$0.23
$0.21
1-Year Range
$0.10
$0.74
$0.21
Latest Close$0.21
Change
+$0.003 (+1.29%)
Volume3,358,084
Market Cap$47.6M
Shares Outstanding414.3M
P/E (TTM)-0.26
Diluted EPS (TTM)-$0.44
Enterprise Value$26.7M
Information as of 06/02/2026
Company Profile
SANGAMO THERAPEUTICS INC
$47.6M
Market Cap
-$122.9M
Net Income
Sector: Healthcare
Industry: Biotechnology
SANGAMO THERAPEUTICS INC
Key Executives
- Alexander D. Macrae Ch.B MRCP
- Nathalie Dubois-Stringfellow
- Scott Willoughby
- Louise Wilkie
- Stephanie J. Seiler
Current Ownership Distribution
- Institutions1.5B (75.65%)
- Mutual Funds439.0M (21.80%)
- Insiders51.4M (2.55%)
- Other0 (0.00%)